Breakthrough technology set to revolutionize sepsis diagnostics

Discover how Inflammatix's new TriVerity™ Acute Infection and Sepsis Test, powered by the Myrna Instrument, is set to revolutionize infection and sepsis diagnostics.

In this video, Inflammatix cofounder and CEO, Tim Sweeney, explores how the TriVerity™ test assesses the immune response to infection, offering highly accurate insights into the presence, type, and severity of infections. Learn how clinicians currently diagnose acute infections and sepsis and see how easy it is to perform the test on the Myrna Instrument.

The TriVerity™ Acute Infection & Sepsis Test System is not for sale. It is currently pending FDA clearance and has not received marketing approval or clearance from regulatory authorities in any jurisdiction.

Interested in learning more or collaborating with Inflammatix? Visit hostresponsedx.com or reach out to info@inflammatix.com

This video was filmed at ADLM 2024 and published for #CLINICAL24 2024.